CIAM
NSPR icon

Caitong International Asset Management’s InspireMD NSPR Stock Holding History

Caitong International Asset Management’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Buy
+1
New +$1 ﹤0.01% 2901

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
AF
Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return

Caitong International Asset Management's NSPR Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in InspireMD (NSPR) in Q2 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #2901 among its holdings.

37 funds tracked by Wall St. Rank hold NSPR as of Q2 2026.

  • Caitong International Asset Management held 1 share of InspireMD worth $1 as of Q2 2026.
  • InspireMD was a new Caitong International Asset Management position in Q2 2026.
  • InspireMD made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2901 holding.
  • 37 funds tracked by Wall St. Rank held InspireMD as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.